Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vicent S"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ruiz-Fernández de Córdoba B; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain., Moreno H; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain., Valencia K; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain.; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Perurena N; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain., Ruedas P; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain., Walle T; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain., Pezonaga-Torres A; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain., Hinojosa J; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain., Guruceaga E; Bioinformatics Core Facility, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain., Pineda-Lucena A; Program of Molecular Therapies, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain., Abengózar-Muela M; Departament of Pathology, Clínica University of Navarra, Pamplona, Spain., Cochonneau D; Nantes Université, CNRS, US2B, UMR 6286, Nantes, France.; Institut de Cancérologie de l'Ouest, Tumor Heterogeneity and Precision Medicine, Saint Herblain, France., Zandueta C; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain., Martínez-Canarias S; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain., Teijeira Á; Immunology and Immunotherapy, CIMA, Pamplona, Spain., Ajona D; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain.; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Ortiz-Espinosa S; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain.; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain., Morales X; Image Core Facility, CIMA, Pamplona, Spain., Ortiz de Solórzano C; Image Core Facility, CIMA, Pamplona, Spain., Santisteban M; Oncology, Clínica University of Navarra, Pamplona, Spain., Ramos-García LI; Radiation Oncology, Clínica University of Navarra, Pamplona, Spain., Guembe L; Morphology Core Facility, CIMA, Pamplona, Spain., Strnad V; Department of Radiation Oncology, University of Erlangen, Erlangen, Germany., Heymann D; Nantes Université, CNRS, US2B, UMR 6286, Nantes, France.; Institut de Cancérologie de l'Ouest, Tumor Heterogeneity and Precision Medicine, Saint Herblain, France.; Department of Oncology and Metabolism, Medical School, Sheffield, UK., Hervás-Stubbs S; Immunology and Immunotherapy, CIMA, Pamplona, Spain., Pío R; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain.; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Rodríguez-Ruiz ME; Immunology and Immunotherapy, CIMA, Pamplona, Spain.; Radiation Oncology, Clínica University of Navarra, Pamplona, Spain., de Andrea CE; Departament of Pathology, Clínica University of Navarra, Pamplona, Spain., Vicent S; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; School of Medicine, Department of Pathology, Anatomy and Physiology, University of Navarra, Pamplona, Spain., Melero I; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Oncology, Clínica University of Navarra, Pamplona, Spain.; School of Medicine, Department of Pathology, Anatomy and Physiology, University of Navarra, Pamplona, Spain., Lecanda F; Solid Tumors Program. Division of Oncology, Center for Applied Medical Research, University of Navarra (CIMA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; School of Medicine, Department of Pathology, Anatomy and Physiology, University of Navarra, Pamplona, Spain., Martínez-Monge R; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Oncology, Clínica University of Navarra, Pamplona, Spain.; Radiation Oncology, Clínica University of Navarra, Pamplona, Spain.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 May 02; Vol. 12 (5), pp. 1356-1377.